myFC sign an exclusive agreement for the fuel cell charger

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
myFC sign an exclusive agreement for the fuel cell charger JAQ in UAE

Swedish myFC have signed an initial agreement with a Telecommunications service provider in UAE, allowing the carrier the exclusive rights to sell, distribute and market myFC’s new fuel cell charger JAQ in the UAE starting in Q2 2016. The agreement between the companies regulates an exclusive right for the carrier to sell, distribute and market myFC’s new fuel cell charger JAQ and the associated power cards to the carriers customers including distribution of JAQ in the company’s shops in the region. MyFC JAQ is a revolutionary fuel cell device that creates its own electricity with a slim, recyclable single-use PowerCard, based on water and salt. The PowerCard delivers about one full smartphone charge. The PowerCards are disposable, and the only emmission they give off in the creation of electricity is water vapour and heat. In the agreement, both partners agreed on pricing for the product and target volumes. The agreed time frame is set to start selling JAQ in the UAE domain beginning Q2 in 2016. For further questions, please contact: Björn Westerholm, CEO E-mail: bjorn.westerholm@myfc.se Telephone: +46 (0) 706 56 20 07 About myFC myFC is a Swedish innovation company that develops energy solutions using fuel cell technology. The company has so far launched two portable fuel cell chargers for small electronics like cell phones, cameras and tablets. Fuel cells use environmentally friendly technology that enables instant charging from a depleted battery state without ever needing a wall charge. myFC was founded in 2005, has its head office in Stockholm and was listed on the NASDAQ OMX First North in May 2014. The company’s Certified Advisor is Remium Nordic AB. To find out more, please visit  www.myfcpower.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading